To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene RRP7ATABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
367 supporting clones for gene RRP7A back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
CF995818 mixed .a 1 to 747 8 to 754   tiling clone,   747/756
(98 %)
6 diff
(99.3 %id)
AK092492 placenta .a 45 to 1791 1 to 1747 P48L tiling clone, available from FLJ,   1747/1747
(100 %)
2 diff
(99.9 %id)
AX747570   .a 45 to 1791 1 to 1747 P48L     1747/1747
(100 %)
2 diff
(99.9 %id)
DA845170 placenta .a 46 to 607 2 to 563   capped   562/562
(100 %)
1 diff
(99.9 %id)
DB328580 placenta .a 1275 to 1791 517 to 1       517/517
(100 %)
0 diff
(100 %id)
NM_015703.4   .b 1 to 5454 2 to 5455 exact RefSeq,   5455/5455
(100 %)
0 diff
(100 %id)
BP314581 mammary gland .b 1 to 580 2 to 581       581/581
(100 %)
2 diff
(99.7 %id)
BP314625 mammary gland .b 1 to 579 2 to 582       582/582
(100 %)
5 diff
(99.2 %id)
BP314657 mammary gland .b 1 to 580 2 to 581       581/581
(100 %)
2 diff
(99.7 %id)
DA157674 amygdala .b 1 to 587 2 to 589   capped   588/588
(100 %)
3 diff
(99.5 %id)
DA164353 amygdala .b 1 to 581 2 to 582   capped   581/581
(100 %)
0 diff
(100 %id)
DA264735 caudate nucleus .b 1 to 555 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DA483217 brain .b 1 to 722 2 to 724   capped   723/725
(99 %)
9 diff
(98.8 %id)
DA496759 brain .b 1 to 584 2 to 585   capped   584/584
(100 %)
1 diff
(99.9 %id)
DA732769   .b 1 to 581 2 to 579   capped   578/578
(100 %)
11 diff
(98.1 %id)
DB197587 trachea .b 1 to 591 2 to 592   capped   591/591
(100 %)
1 diff
(99.9 %id)
DB264948 uterus .b 1 to 591 2 to 592   tiling clone, capped   591/591
(100 %)
0 diff
(100 %id)
DA106256 cerebellum .b 3 to 560 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DA165879 amygdala .b 3 to 578 2 to 579   capped   578/578
(100 %)
4 diff
(99.4 %id)
DA387219 thalamus .b 3 to 590 2 to 590   capped   589/589
(100 %)
3 diff
(99.5 %id)
DB179832 kidney, tumor tissue .b 3 to 558 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
DB248378 uterus .b 3 to 620 2 to 619   capped   618/618
(100 %)
3 diff
(99.6 %id)
DA728765   .b 9 to 739 2 to 739   capped   738/739
(99 %)
11 diff
(98.6 %id)
BF979147 melanotic melanoma, high MDR, skin .b 10 to 669 1 to 658       658/659
(99 %)
10 diff
(98.5 %id)
DA775871 brain .b 10 to 592 2 to 585   capped   584/584
(100 %)
3 diff
(99.5 %id)
BU601931 mixed (pool of 40 RNAs) .b 14 to 866 1 to 855       855/855
(100 %)
26 diff
(97.0 %id)
DR155560 human embryonic stem cells differentiated toan early endodermal cell type .b 14 to 684 1 to 671       671/671
(100 %)
3 diff
(99.6 %id)
BC121118 PCR rescued clones .b 17 to 1130 1 to 1114 exact     1114/1114
(100 %)
4 diff
(99.7 %id)
BC121119 PCR rescued clones .b 17 to 1130 1 to 1114 exact     1114/1114
(100 %)
4 diff
(99.7 %id)
EC548516 Prostate .b 18 to 123 1 to 106       106/106
(100 %)
0 diff
(100 %id)
BE514431 Burkitt lymphoma, lymph .b 18 to 736 27 to 739       713/740
(96 %)
15 diff
(98.0 %id)
BE561882 Burkitt lymphoma, lymph .b 18 to 793 31 to 803       773/977
(79 %)
30 diff
(97.0 %id)
BG502125 embryonal carcinoma, testis .b 18 to 787 1 to 779       779/780
(99 %)
21 diff
(97.4 %id)
BG547405 lung .b 18 to 792 1 to 777       777/783
(99 %)
14 diff
(98.3 %id)
BQ069189 brain, neuroblastoma, cell line .b 19 to 918 33 to 938 R258P K259R D264E E269Q     906/1021
(88 %)
20 diff
(98.1 %id)
DA157101 amygdala .b 20 to 605 2 to 587   capped   586/586
(100 %)
3 diff
(99.5 %id)
DA171075 amygdala .b 20 to 561 2 to 543   capped   542/542
(100 %)
0 diff
(100 %id)
DA354862 substantia nigra .b 20 to 593 2 to 576   capped   575/575
(100 %)
5 diff
(99.2 %id)
BQ070685 brain, neuroblastoma, cell line .b 20 to 1011 1 to 1006 E200X S249R K250Q R267K Q274H ...     1006/1014
(99 %)
39 diff
(96.2 %id)
BQ896153 brain, neuroblastoma, cell line .b 20 to 943 1 to 925 A191G E229G R230D R231G K232S ...     925/930
(99 %)
32 diff
(96.6 %id)
DA809359 brain .b 20 to 611 2 to 594   capped   593/593
(100 %)
1 diff
(99.9 %id)
BC035992 Testis, embryonal carcinoma .b 21 to 1220 1 to 1200 exact available from MGC, AAA   1200/1200
(100 %)
0 diff
(100 %id)
DA678303   .b 22 to 793 2 to 775   capped   774/842
(91 %)
9 diff
(99.0 %id)
CR622688 T cells (Jurkat cell line) Cot10-normalized .b 23 to 1242 1 to 1220 exact     1220/1220
(100 %)
0 diff
(100 %id)
EC466621 Prostate .b 25 to 133 1 to 109       109/110
(99 %)
8 diff
(92.8 %id)
BE241712 leukopheresis .b 25 to 315 1 to 291       291/291
(100 %)
7 diff
(97.6 %id)
CR598821 neuroblastoma .b 26 to 1214 1 to 1189 exact     1189/1189
(100 %)
0 diff
(100 %id)
BX424719 placenta .b 26 to 886 1 to 859 E172X V173S D174G T175H F176V ...     859/864
(99 %)
37 diff
(95.8 %id)
BC064560 Skin, melanotic melanoma. .b 26 to 1226 1 to 1201 R235* available from MGC, AAA   1201/1201
(100 %)
1 diff
(100.0 %id)
BM549445 melanotic melanoma, skin .b 26 to 921 1 to 896 R235* available from MGC,   896/1060
(84 %)
4 diff
(99.7 %id)
BE244153 leukopheresis .b 26 to 277 1 to 251       251/251
(100 %)
4 diff
(98.5 %id)
BC073834 Uterus, leiomyosarcoma .b 27 to 3806 1 to 3778 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 3778/3778
(100 %)
1 diff
(100.0 %id)
CF994127 Human Placenta, placenta .b 27 to 885 28 to 897 E229G R230E R231T K232E R233A ...     870/919
(94 %)
25 diff
(97.3 %id)
DA291556 hippocampus .b 28 to 620 2 to 594   capped   593/593
(100 %)
3 diff
(99.5 %id)
DA393359 thalamus .b 28 to 612 2 to 587   capped   586/586
(100 %)
4 diff
(99.4 %id)
BG500619 adenocarcinoma, Prostate .b 28 to 549 1 to 522       522/522
(100 %)
0 diff
(100 %id)
BM453534 leiomyosarcoma, uterus .b 28 to 765 1 to 744       744/991
(75 %)
18 diff
(98.2 %id)
DA938137 Spleen .b 28 to 609 2 to 585   capped   584/584
(100 %)
3 diff
(99.5 %id)
AL602694 human skeletal muscle .b 29 to 638 1 to 611       611/611
(100 %)
3 diff
(99.6 %id)
BP231193 muscle .b 29 to 609 1 to 582       582/582
(100 %)
3 diff
(99.5 %id)
DB451321 testis .b 29 to 496 1 to 468       468/476
(98 %)
4 diff
(99.2 %id)
DA033823   .b 30 to 604 2 to 576   capped   575/575
(100 %)
2 diff
(99.7 %id)
DA354502 substantia nigra .b 30 to 616 2 to 589   capped   588/588
(100 %)
4 diff
(99.4 %id)
DA368143 subthalamic nucleus .b 30 to 603 2 to 578   capped   577/577
(100 %)
4 diff
(99.4 %id)
DA393349 thalamus .b 30 to 630 2 to 603   capped   602/602
(100 %)
4 diff
(99.4 %id)
DA435704 tongue, tumor tissue .b 30 to 605 2 to 577   capped   576/576
(100 %)
3 diff
(99.5 %id)
BX955878   .b 30 to 197 1 to 168       168/168
(100 %)
0 diff
(100 %id)
DA586321 lung .b 30 to 613 2 to 585   capped   584/584
(100 %)
2 diff
(99.7 %id)
DA590824 lung .b 30 to 603 2 to 576   capped   575/575
(100 %)
3 diff
(99.5 %id)
BI225876 Burkitt lymphoma, lymph .b 30 to 885 1 to 859 P213L V214C L215S R217G T218L ...     857/864
(99 %)
14 diff
(98.4 %id)
DA740336   .b 30 to 542 2 to 514   capped   513/513
(100 %)
0 diff
(100 %id)
DA942515 Spleen .b 30 to 618 2 to 590   capped   589/589
(100 %)
2 diff
(99.7 %id)
BG757145 B-cells, primary B-cells from tonsils (cell line) .b 31 to 937 10 to 912 D174G T175H F176V M177H E178G ...     903/987
(91 %)
44 diff
(95.6 %id)
BG754755 B-cells, primary B-cells from tonsils (cell line) .b 31 to 947 10 to 925 A221G S222Q R224A V225G L226A ...     916/951
(96 %)
39 diff
(95.9 %id)
DA252834 caudate nucleus .b 32 to 609 2 to 579   capped   578/578
(100 %)
4 diff
(99.4 %id)
DA296199 hippocampus .b 32 to 582 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
DA298827 hippocampus .b 32 to 602 2 to 572   capped   571/575
(99 %)
5 diff
(99.2 %id)
DA390340 thalamus .b 32 to 612 2 to 582   capped   581/581
(100 %)
3 diff
(99.5 %id)
DA392944 thalamus .b 32 to 618 2 to 589   capped   588/588
(100 %)
3 diff
(99.5 %id)
DA530311 brain .b 32 to 631 2 to 601   capped   600/600
(100 %)
4 diff
(99.4 %id)
BF315062 brain, neuroblastoma .b 32 to 799 1 to 758       758/795
(95 %)
23 diff
(97.2 %id)
BG261036 bladder, transitional cell papilloma, cell line .b 32 to 793 1 to 759       759/861
(88 %)
24 diff
(97.3 %id)
DA784803 brain .b 32 to 605 2 to 577   capped   576/576
(100 %)
3 diff
(99.5 %id)
BP320374 placenta .b 32 to 623 1 to 592       592/592
(100 %)
3 diff
(99.5 %id)
DA877099 Prostate .b 32 to 617 2 to 587   capped   586/586
(100 %)
0 diff
(100 %id)
DA906941   .b 32 to 615 2 to 586   capped   585/585
(100 %)
4 diff
(99.4 %id)
EC493098 Prostate .b 33 to 128 11 to 107       97/107
(90 %)
6 diff
(94.4 %id)
BP262936 small intestine .b 33 to 615 1 to 583       583/583
(100 %)
5 diff
(99.2 %id)
DB206663 trachea .b 33 to 613 2 to 584   capped   583/583
(100 %)
5 diff
(99.2 %id)
AK314650 trachea .b 34 to 879 1 to 846 E102K     846/846
(100 %)
1 diff
(99.9 %id)
CD049990 embryonic stem cells, WA01, passage 38 .b 34 to 899 23 to 891 F261V E262R E263G D264G K265Q ...     869/896
(96 %)
17 diff
(98.2 %id)
BP253192 Kidney .b 34 to 615 1 to 582       582/582
(100 %)
3 diff
(99.5 %id)
BF311680 brain, neuroblastoma .b 34 to 799 1 to 762       762/787
(96 %)
20 diff
(97.5 %id)
BI199761 brain, neuroblastoma .b 34 to 682 1 to 646       646/646
(100 %)
9 diff
(98.7 %id)
BQ939833 epidermoid carcinoma, cell line, lung .b 34 to 761 27 to 759       733/903
(81 %)
24 diff
(97.4 %id)
DA878581 Prostate .b 34 to 601 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DA210700 brain .b 35 to 606 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA218961 brain .b 35 to 638 2 to 607   capped   606/606
(100 %)
2 diff
(99.7 %id)
CN306177 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 36 to 690 1 to 658       658/658
(100 %)
5 diff
(99.3 %id)
BX407062 brain, fetal brain .b 37 to 1001 1 to 958 V85I D181X E193X R208X V214G ...     958/968
(98 %)
20 diff
(98.0 %id)
BX441277 brain, fetal brain .b 37 to 946 1 to 904 V85I D199X P213L V214C L215S ...     904/904
(100 %)
13 diff
(98.6 %id)
EC462059 Prostate .b 37 to 142 1 to 106       106/106
(100 %)
0 diff
(100 %id)
BG684167 B-cells, primary B-cells from tonsils (cell line) .b 37 to 781 1 to 745       745/746
(99 %)
6 diff
(99.2 %id)
BM559553 brain, medulla .b 37 to 744 75 to 790   available from MGC,   716/1484
(48 %)
22 diff
(98.6 %id)
BU540541 large cell carcinoma, lung .b 37 to 923 1 to 889 E263G K276X     889/890
(99 %)
5 diff
(99.5 %id)
CN306170 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 38 to 715 1 to 678       678/678
(100 %)
3 diff
(99.6 %id)
BI857755 breast, mammary adenocarcinoma, cell line .b 39 to 765 1 to 730       730/731
(99 %)
7 diff
(99.1 %id)
BM051000 eye, normal pigmented retinal epithelium .b 39 to 834 1 to 797       797/802
(99 %)
16 diff
(98.1 %id)
BC042335 Brain, adult medulla .b 39 to 1210 1 to 1172   available from MGC, AAA   1172/1172
(100 %)
2 diff
(99.9 %id)
BQ220597 melanotic melanoma, skin .b 39 to 873 1 to 841       841/895
(93 %)
15 diff
(98.4 %id)
BU182740 melanotic melanoma, skin .b 39 to 787 1 to 759       759/903
(84 %)
28 diff
(96.9 %id)
TI_57190929   .b 39 to 765 55 to 784       730/731
(99 %)
7 diff
(99.1 %id)
CN306173 embryonic stem cells, cell lines H1, H7, andH9 .b 40 to 547 1 to 508       508/508
(100 %)
0 diff
(100 %id)
EC458656 Prostate .b 40 to 148 1 to 112       112/112
(100 %)
8 diff
(92.9 %id)
ES312843 beard hair, skin .b 40 to 221 1 to 181       181/181
(100 %)
3 diff
(98.4 %id)
EC485143 Prostate .b 41 to 146 1 to 102       102/102
(100 %)
5 diff
(95.1 %id)
BG386120 adenocarcinoma cell line, colon .b 41 to 792 1 to 759       759/957
(79 %)
22 diff
(97.8 %id)
BG469906 adenocarcinoma cell line, colon .b 41 to 683 1 to 647       647/650
(99 %)
9 diff
(98.7 %id)
BM012054 brain, neuroblastoma, cell line .b 41 to 741 1 to 706       706/873
(80 %)
17 diff
(98.1 %id)
BQ051956 blood, natural killer cells, cell line .b 41 to 696 1 to 659       659/1133
(58 %)
9 diff
(99.3 %id)
CN306178 embryonic stem cells, DMSO-treated H9 cellline .b 42 to 569 1 to 528       528/528
(100 %)
0 diff
(100 %id)
EC455476 Prostate .b 42 to 146 1 to 105       105/105
(100 %)
0 diff
(100 %id)
EC540362 Prostate .b 42 to 148 1 to 107       107/107
(100 %)
0 diff
(100 %id)
EC542841 Prostate .b 42 to 148 1 to 107       107/107
(100 %)
4 diff
(96.3 %id)
EC570845 Prostate .b 42 to 146 1 to 104       104/104
(100 %)
1 diff
(99.1 %id)
EC578231 Prostate .b 42 to 148 1 to 106       106/106
(100 %)
5 diff
(95.3 %id)
BC041639 Lymph, Burkitt lymphoma .b 42 to 1227 1 to 1186   available from MGC,   1186/1187
(99 %)
1 diff
(100.0 %id)
BM472241 melanotic melanoma, skin .b 42 to 951 47 to 958       912/1068
(85 %)
33 diff
(97.0 %id)
CA453998   .b 42 to 850 26 to 853       828/900
(92 %)
39 diff
(95.7 %id)
CF128520 Chondrosarcoma Lung Metastasis cell lines, lung .b 42 to 654 1 to 613       613/613
(100 %)
3 diff
(99.6 %id)
TI_59381249   .b 42 to 741 115 to 819       705/872
(80 %)
16 diff
(98.2 %id)
TI_154194429   .b 42 to 980 40 to 971       932/1058
(88 %)
28 diff
(97.4 %id)
CR591597 fetal brain .b 44 to 2835 1 to 2792   tiling clone,   2792/2792
(100 %)
0 diff
(100 %id)
BX419832 brain, fetal brain .b 44 to 952 1 to 904       904/904
(100 %)
14 diff
(98.5 %id)
EC491018 Prostate .b 44 to 148 1 to 105       105/105
(100 %)
0 diff
(100 %id)
EC506153 Prostate .b 44 to 148 1 to 106       106/106
(100 %)
1 diff
(99.1 %id)
EC572719 Prostate .b 44 to 148 1 to 105       105/105
(100 %)
0 diff
(100 %id)
BM463858 melanotic melanoma, skin .b 44 to 793 1 to 758       758/1122
(67 %)
16 diff
(98.6 %id)
CN306179 embryonic stem cells, cell lines H1, H7, andH9 .b 45 to 716 1 to 672       672/672
(100 %)
0 diff
(100 %id)
CX752989 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 45 to 799 1 to 746     Submitted on the opposite strand 746/804
(92 %)
20 diff
(97.6 %id)
CN306171 embryonic stem cells, DMSO-treated H9 cellline .b 46 to 713 1 to 668       668/668
(100 %)
0 diff
(100 %id)
BG035365 adenocarcinoma, cell line, Liver .b 46 to 790 1 to 749       749/1124
(66 %)
8 diff
(99.3 %id)
BG180492 adenocarcinoma, cell line, Prostate .b 46 to 760 1 to 720       720/1165
(61 %)
27 diff
(97.7 %id)
BG479837 choriocarcinoma, placenta .b 47 to 936 1 to 893       893/921
(96 %)
38 diff
(95.9 %id)
BI256429 cervical carcinoma cell line, cervix .b 47 to 663 1 to 618       618/618
(100 %)
3 diff
(99.6 %id)
BM012093 brain, neuroblastoma, cell line .b 47 to 793 1 to 746       746/809
(92 %)
9 diff
(98.9 %id)
TI_59381290   .b 47 to 793 105 to 850       746/809
(92 %)
9 diff
(98.9 %id)
ES312301 frontal balding hair, skin .b 48 to 264 1 to 217       217/217
(100 %)
0 diff
(100 %id)
BI820505 pooled brain, lung, testis .b 51 to 874 1 to 826       826/826
(100 %)
9 diff
(99.0 %id)
BQ896884 ductal carcinoma, cell line, Pancreas .b 51 to 951 1 to 904       904/906
(99 %)
13 diff
(98.6 %id)
TI_57198878   .b 51 to 874 66 to 891       826/891
(92 %)
14 diff
(98.5 %id)
CN306172 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 52 to 550 1 to 499       499/499
(100 %)
0 diff
(100 %id)
EC475145 Prostate .b 52 to 158 1 to 106       106/106
(100 %)
6 diff
(94.4 %id)
EC483361 Prostate .b 52 to 148 18 to 113       96/113
(84 %)
6 diff
(94.7 %id)
BE408973 choriocarcinoma, placenta .b 53 to 750 1 to 698       698/705
(99 %)
11 diff
(98.5 %id)
BQ057208 lymph, lymphoma, cell line .b 53 to 1027 1 to 989       989/989
(100 %)
47 diff
(95.3 %id)
BQ717075 sympathetic trunk .b 53 to 793 1 to 744       744/840
(88 %)
16 diff
(98.1 %id)
BQ898549 lymph, lymphoma, cell line .b 53 to 800 1 to 753       753/935
(80 %)
17 diff
(98.2 %id)
BE313212 brain, neuroblastoma .b 54 to 694 1 to 643       643/746
(86 %)
14 diff
(98.2 %id)
BQ061644 lymph, lymphoma, cell line .b 54 to 790 1 to 738       738/1061
(69 %)
6 diff
(99.5 %id)
BQ062377 lymph, lymphoma, cell line .b 54 to 999 1 to 957       957/1043
(91 %)
27 diff
(97.5 %id)
BE384699 melanotic melanoma, skin .b 59 to 768 1 to 704       704/769
(91 %)
11 diff
(98.6 %id)
BE796383 lung, small cell carcinoma .b 59 to 793 1 to 730       730/757
(96 %)
7 diff
(99.1 %id)
BE269525 Burkitt lymphoma, lymph .b 60 to 722 1 to 662       662/669
(98 %)
5 diff
(99.3 %id)
BE384987 melanotic melanoma, skin .b 65 to 654 1 to 590       590/590
(100 %)
2 diff
(99.7 %id)
BE795565 lung, small cell carcinoma .b 65 to 793 1 to 720       720/979
(73 %)
15 diff
(98.5 %id)
BE409365 choriocarcinoma, placenta .b 68 to 745 1 to 674       674/736
(91 %)
13 diff
(98.3 %id)
BE407410 choriocarcinoma, placenta .b 69 to 757 1 to 692       692/728
(95 %)
18 diff
(97.6 %id)
BE396306 Burkitt lymphoma, lymph .b 75 to 863 1 to 787       787/792
(99 %)
16 diff
(98.0 %id)
BC031838 Duodenum, adenocarcinoma .b 85 to 2594 1 to 2510   available from MGC, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 2510/2510
(100 %)
5 diff
(99.9 %id)
TI_154143097   .b 88 to 647 86 to 646       561/566
(99 %)
10 diff
(98.3 %id)
BG489416 large cell carcinoma, lung .b 108 to 793 1 to 690       690/962
(71 %)
9 diff
(99.1 %id)
CN306180 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 118 to 706 1 to 589       589/589
(100 %)
5 diff
(99.2 %id)
BE378582 endometrium, adenocarcinoma cell line, uterus .b 118 to 1064 1 to 935       935/1122
(83 %)
66 diff
(94.2 %id)
CF125656 Chondrosarcoma Lung Metastasis cell lines, lung .b 123 to 824 1 to 702       702/702
(100 %)
4 diff
(99.5 %id)
TI_154186583   .b 123 to 844 51 to 772       722/723
(99 %)
6 diff
(99.2 %id)
AY039240 gastric adenocarcinoma .b 128 to 1227 1 to 1100       1100/1102
(99 %)
1 diff
(100.0 %id)
CF125484 Chondrosarcoma Lung Metastasis cell lines, lung .b 129 to 819 1 to 690       690/690
(100 %)
5 diff
(99.3 %id)
TI_154187138   .b 129 to 840 43 to 753       711/711
(100 %)
5 diff
(99.3 %id)
D63260   .b 141 to 434 1 to 294       294/294
(100 %)
0 diff
(100 %id)
TI_154195775   .b 144 to 1139 25 to 1016       992/1099
(90 %)
52 diff
(95.3 %id)
BM741752 Ascites, stomach .b 157 to 793 1 to 637       637/643
(99 %)
4 diff
(99.4 %id)
BU507853 leiomyosarcoma, uterus .b 162 to 1007 1 to 856       856/857
(99 %)
9 diff
(99.0 %id)
BG750048 eye, normal pigmented retinal epithelium .b 164 to 990 1 to 840       840/840
(100 %)
31 diff
(96.4 %id)
TI_59391477   .b 166 to 1054 53 to 943       891/892
(99 %)
22 diff
(97.6 %id)
BM737786 Ascites, stomach .b 168 to 781 1 to 614       614/614
(100 %)
2 diff
(99.7 %id)
TI_57187192   .b 173 to 980 48 to 857       810/811
(99 %)
7 diff
(99.2 %id)
BX328861   .b 175 to 1113 1 to 925       925/927
(99 %)
19 diff
(98.0 %id)
BX384896   .b 175 to 943 1 to 779       694/1038
(66 %)
43 diff
(95.9 %id)
BI858219 breast, mammary adenocarcinoma, cell line .b 175 to 980 1 to 808       808/809
(99 %)
7 diff
(99.2 %id)
CF128425 Chondrosarcoma Lung Metastasis cell lines, lung .b 178 to 912 1 to 735       735/735
(100 %)
0 diff
(100 %id)
TI_154194297   .b 178 to 1201 48 to 1068   AAA   1021/1041
(98 %)
34 diff
(96.8 %id)
DN992611 brain, whole brain .b 206 to 833 1 to 627       627/627
(100 %)
4 diff
(99.4 %id)
DB007802 cervix, tumor tissue .b 220 to 692 2 to 474   capped   473/473
(100 %)
0 diff
(100 %id)
BX328860   .b 245 to 1199 948 to 1       948/1009
(93 %)
23 diff
(97.8 %id)
BQ671019 epidermoid carcinoma, cell line, salivary gland .b 246 to 1064 1 to 824       824/874
(94 %)
9 diff
(99.0 %id)
BG029832 breast, mammary adenocarcinoma, cell line .b 253 to 663 1 to 410       410/410
(100 %)
1 diff
(99.8 %id)
TI_45236107   .b 258 to 1133 60 to 926       867/941
(92 %)
30 diff
(96.9 %id)
BI517893 pooled colon, kidney, stomach .b 265 to 1133 1 to 860       860/875
(98 %)
29 diff
(96.7 %id)
BU178576 melanotic melanoma, skin .b 283 to 1083 1 to 814       814/854
(95 %)
28 diff
(96.8 %id)
BE336626 adenocarcinoma cell line, ovary .b 290 to 784 1 to 495       495/497
(99 %)
10 diff
(98.0 %id)
AA306027   .b 291 to 736 1 to 444       444/444
(100 %)
4 diff
(99.1 %id)
BQ686123 ductal carcinoma, cell line, Pancreas .b 298 to 1091 9 to 807       797/951
(83 %)
24 diff
(97.5 %id)
H97316   .b 307 to 597 1 to 291       291/291
(100 %)
1 diff
(99.7 %id)
BG421727 Kidney, renal cell adenocarcinoma .b 342 to 917 1 to 578       578/578
(100 %)
4 diff
(99.4 %id)
DA622643 Kidney .b 358 to 915 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
TI_149295034   .b 379 to 1220 910 to 73   AAA   838/956
(87 %)
13 diff
(98.7 %id)
BX376853 Neuroblastoma Cot 50-normalized .b 382 to 1227 843 to 1     Submitted on the opposite strand 843/927
(90 %)
6 diff
(99.4 %id)
TI_57186672   .b 405 to 1220 54 to 881   AAA   828/828
(100 %)
17 diff
(98.0 %id)
BI857034 breast, mammary adenocarcinoma, cell line .b 406 to 1220 1 to 827   AAA   827/827
(100 %)
17 diff
(98.0 %id)
TI_159718839   .b 414 to 1230 901 to 86   AAA   816/1057
(77 %)
3 diff
(99.8 %id)
BX328859   .b 419 to 1226 823 to 17   AAA   807/807
(100 %)
27 diff
(96.7 %id)
BE563211 adenocarcinoma, Pancreas .b 461 to 1215 1 to 753       753/759
(99 %)
17 diff
(97.8 %id)
BF880523.
matches multiple genes
lung_tumor .b 471 to 607 7 to 142     also hits gene RRP7B 136/142
(95 %)
8 diff
(94.4 %id)
BE407192 choriocarcinoma, placenta .b 474 to 984 1 to 511       511/512
(99 %)
3 diff
(99.5 %id)
BE536740 cervix .b 498 to 911 1 to 415       415/415
(100 %)
1 diff
(99.8 %id)
BE267730 Burkitt lymphoma, lymph .b 499 to 1090 1 to 592       592/592
(100 %)
0 diff
(100 %id)
BE267873.
matches multiple genes
Burkitt lymphoma, lymph .b 499 to 793 1 to 296     also hits gene RRP7B 296/303
(97 %)
2 diff
(99.4 %id)
BC063537 Liver, adenocarcinoma .b 504 to 1220 1 to 717   available from MGC, AAA   717/717
(100 %)
0 diff
(100 %id)
BG117511.
matches multiple genes
adenocarcinoma, cell line, Liver .b 505 to 663 1 to 159   available from MGC, also hits gene RRP7B 159/159
(100 %)
0 diff
(100 %id)
CB852698 Human Lung Epithelial cells, lung .b 512 to 1230 736 to 19   AAA   718/718
(100 %)
1 diff
(99.9 %id)
TI_149292989   .b 538 to 1240 762 to 63   AAA   702/802
(87 %)
11 diff
(98.7 %id)
BU683540 lung .b 542 to 1220 697 to 19   AAA   679/679
(100 %)
1 diff
(99.9 %id)
BM997182 Chondrosarcoma, Left Pubic Bone .b 543 to 1232 706 to 17   AAA   690/690
(100 %)
0 diff
(100 %id)
CA309179 Alveolar Macrophage, lung .b 543 to 1230 705 to 19   AAA   687/687
(100 %)
1 diff
(99.9 %id)
BQ447937 Knee, Osteoarthritic Cartilage .b 548 to 1232 700 to 17   AAA   684/684
(100 %)
2 diff
(99.8 %id)
BM798488.
matches multiple genes
Ascites, stomach .b 567 to 691 1 to 125     also hits gene RRP7B 125/125
(100 %)
3 diff
(97.6 %id)
BF033125.
matches multiple genes
adenocarcinoma, ovary .b 572 to 643 1 to 72     also hits gene RRP7B 72/72
(100 %)
0 diff
(100 %id)
BQ053749 blood, natural killer cells, cell line .b 593 to 1556 1 to 976       976/1014
(96 %)
30 diff
(97.1 %id)
BU558000 adenocarcinoma, cell line, breast .b 594 to 837 11 to 254       244/254
(96 %)
6 diff
(97.7 %id)
BM705093 eye, RPE and Choroid .b 601 to 1094 1 to 493       493/493
(100 %)
3 diff
(99.4 %id)
CD369366 Alveolar Macrophage, lung .b 601 to 1226 642 to 19   AAA   624/624
(100 %)
2 diff
(99.7 %id)
BU183383 melanotic melanoma, skin .b 638 to 1230 1 to 593   AAA   593/593
(100 %)
0 diff
(100 %id)
BP375913 uterus .b 645 to 1224 1 to 580       580/580
(100 %)
0 diff
(100 %id)
AW612943 colon, moderately-differentiated adenocarcinoma .b 652 to 1237 586 to 1       586/586
(100 %)
3 diff
(99.5 %id)
AA306925   .b 653 to 1122 1 to 467       467/467
(100 %)
6 diff
(98.8 %id)
BQ220519 melanotic melanoma, skin .b 653 to 1512 1 to 862       862/863
(99 %)
6 diff
(99.4 %id)
BX368919   .b 664 to 1227 1 to 564       564/577
(97 %)
2 diff
(99.7 %id)
BX407231 brain, fetal brain .b 667 to 1549 1 to 872       872/997
(87 %)
37 diff
(96.3 %id)
CV342814 stomach .b 677 to 1173 14 to 523       510/523
(97 %)
39 diff
(92.6 %id)
AI143114 heart .b 687 to 1210 524 to 1       524/524
(100 %)
0 diff
(100 %id)
TI_154147787   .b 705 to 1227 79 to 601       523/527
(99 %)
3 diff
(99.5 %id)
BM456220 lymph, lymphoma, cell line .b 724 to 1485 1 to 766       766/826
(92 %)
21 diff
(97.5 %id)
BE268915 Burkitt lymphoma, lymph .b 728 to 1122 1 to 390   AAA   390/465
(83 %)
17 diff
(96.4 %id)
TI_57189817   .b 737 to 1218 56 to 538   AAA   483/483
(100 %)
1 diff
(99.8 %id)
AI199199 anaplastic oligodendroglioma, brain .b 739 to 1221 483 to 1       483/483
(100 %)
0 diff
(100 %id)
BX374257   .b 741 to 1224 483 to 1       483/579
(83 %)
16 diff
(97.3 %id)
AI159848 brain, glioblastoma (pooled) .b 757 to 1221 465 to 1       465/465
(100 %)
0 diff
(100 %id)
AW009857 colon .b 769 to 1226 458 to 1       458/458
(100 %)
0 diff
(100 %id)
BF435926 pooled .b 772 to 1232 461 to 1       461/461
(100 %)
0 diff
(100 %id)
BF112054 pooled .b 772 to 1232 461 to 1       461/461
(100 %)
0 diff
(100 %id)
DB516797 testis .b 781 to 1223 1 to 443     Submitted on the opposite strand 443/444
(99 %)
1 diff
(99.8 %id)
BQ066507 lymph, lymphoma, cell line .b 790 to 1226 1 to 437   AAA   437/437
(100 %)
0 diff
(100 %id)
BX368820 Placenta Cot 25-normalized .b 794 to 1633 1 to 849       849/877
(96 %)
34 diff
(96.2 %id)
EC450108.
matches multiple genes
Prostate .b 794 to 869 17 to 93     also hits gene RRP7B 77/93
(82 %)
6 diff
(93.6 %id)
BM798426 Ascites, stomach .b 796 to 919 1 to 124       124/124
(100 %)
9 diff
(92.8 %id)
BX409563 brain, fetal brain .b 797 to 1677 1 to 878       878/883
(99 %)
19 diff
(97.9 %id)
BX428452 brain, fetal brain .b 807 to 1687 1 to 882       882/993
(88 %)
21 diff
(97.9 %id)
BX409561 brain, fetal brain .b 816 to 1569 1 to 751       751/858
(87 %)
15 diff
(98.3 %id)
AW016397   .b 835 to 1232 413 to 16   AAA   398/398
(100 %)
0 diff
(100 %id)
AI358502 serous papillary carcinoma, high grade, 2pooled tumors, uterus .b 843 to 1234 392 to 1       392/392
(100 %)
0 diff
(100 %id)
AI989730 colon, colonic mucosa from 3 patients with Crohn'sdisease .b 852 to 1232 401 to 21   AAA   381/382
(99 %)
0 diff
(100 %id)
AW381946 head_neck .b 865 to 1164 1 to 311       311/329
(94 %)
22 diff
(93.4 %id)
BM918088 blood, natural killer cells, cell line .b 917 to 1689 1 to 779       779/1111
(70 %)
23 diff
(98.0 %id)
BF981769 duodenal adenocarcinoma, cell line, small intestine .b 942 to 1232 1 to 291   AAA   291/291
(100 %)
0 diff
(100 %id)
BE242114 leukopheresis .b 1010 to 1226 218 to 1       218/218
(100 %)
3 diff
(98.7 %id)
BE243352 leukopheresis .b 1014 to 1226 213 to 1       213/213
(100 %)
4 diff
(98.2 %id)
AI886250 serous papillary carcinoma, high grade, 2pooled tumors, uterus .b 1094 to 1226 159 to 26   AAA   134/134
(100 %)
3 diff
(97.8 %id)
AA760697 germinal center B cell .b 1104 to 1226 182 to 60   AAA   123/123
(100 %)
1 diff
(99.2 %id)
BG395933 eye, retinoblastoma .b 1190 to 1984 1 to 792       792/799
(99 %)
28 diff
(96.5 %id)
BF983557 duodenal adenocarcinoma, cell line, small intestine .b 1230 to 2061 1 to 835       835/943
(88 %)
34 diff
(96.4 %id)
BY993799   .b 1351 to 1979 6 to 635       630/635
(99 %)
6 diff
(99.1 %id)
BX451250 brain, fetal brain .b 1487 to 1687 711 to 909       813/910
(89 %)
24 diff
(97.4 %id)
BX409063 brain, fetal brain .b 1523 to 2047 519 to 1       519/589
(88 %)
25 diff
(95.8 %id)
BE276923 melanotic melanoma, skin .b 1548 to 2174 1 to 629       629/631
(99 %)
6 diff
(99.1 %id)
CK000522 mixed .b 1602 to 2388 1 to 786       786/788
(99 %)
6 diff
(99.3 %id)
BU553670 ovary, teratocarcinoma, cell line .b 1705 to 2610 1 to 911       911/920
(99 %)
13 diff
(98.6 %id)
AW402711 lymph .b 1758 to 2257 1 to 500       500/500
(100 %)
5 diff
(99.0 %id)
TI_154139138   .b 1765 to 2394 81 to 709       629/629
(100 %)
2 diff
(99.7 %id)
BE277019 melanotic melanoma, skin .b 1848 to 2530 1 to 682       682/682
(100 %)
3 diff
(99.6 %id)
AA344886 gall bladder .b 1869 to 2075 1 to 207       207/207
(100 %)
0 diff
(100 %id)
CA309270 Alveolar Macrophage, lung .b 1869 to 2594 742 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 724/724
(100 %)
4 diff
(99.5 %id)
BX419831 brain, fetal brain .b 1877 to 2747 962 to 90       873/962
(90 %)
0 diff
(100 %id)
CD366265 Alveolar Macrophage, lung .b 1902 to 2594 708 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 690/690
(100 %)
3 diff
(99.6 %id)
AI951668 fibrotheoma, ovary .b 1943 to 2432 490 to 1       490/490
(100 %)
0 diff
(100 %id)
DA207251 brain .b 1997 to 2569 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DB353806   .b 2018 to 2594 573 to 1       573/580
(98 %)
17 diff
(97.1 %id)
TI_154135378   .b 2109 to 2857 839 to 96       744/1015
(73 %)
0 diff
(100 %id)
DB364390   .b 2126 to 2594 467 to 1       467/499
(93 %)
8 diff
(98.4 %id)
AI683330 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 2135 to 2595 461 to 1       461/461
(100 %)
0 diff
(100 %id)
EL954014 eyeball .b 2233 to 2723 25 to 515       491/515
(95 %)
6 diff
(98.9 %id)
BE162935 head_neck .b 3211 to 3506 1 to 296       296/296
(100 %)
0 diff
(100 %id)
DB304243 brain .b 3265 to 3806 542 to 1       542/542
(100 %)
0 diff
(100 %id)
AI867044 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .b 3382 to 3809 428 to 1       428/428
(100 %)
0 diff
(100 %id)
DT218147 brain .b 3476 to 4086 1 to 613   tiling clone,   613/613
(100 %)
6 diff
(99.1 %id)
CV801163 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 3779 to 4510 1 to 725   tiling clone,   725/864
(83 %)
11 diff
(98.8 %id)
R56529 whole brain .b 3873 to 4295 1 to 427     Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 427/460
(92 %)
17 diff
(96.4 %id)
AA326321 brain, cerebellum .b 3897 to 4188 1 to 292       292/292
(100 %)
0 diff
(100 %id)
BE407296 choriocarcinoma, placenta .b 3974 to 4475 1 to 510       510/512
(99 %)
11 diff
(97.9 %id)
BE384666 melanotic melanoma, skin .b 3975 to 4401 1 to 426       426/763
(55 %)
5 diff
(99.4 %id)
BQ374277 prostate_tumor .b 3988 to 4276 43 to 330       288/330
(87 %)
6 diff
(98.2 %id)
BQ051061 leiomyosarcoma, uterus .b 4011 to 4843 1 to 845       845/1072
(78 %)
35 diff
(96.8 %id)
CB147891.
matches multiple genes
Liver .b 4143 to 4604 1 to 462   tiling clone, also hits gene RRP7B 462/462
(100 %)
6 diff
(98.8 %id)
DA795988 brain .b 4284 to 4753 2 to 471   tiling clone, capped   470/470
(100 %)
0 diff
(100 %id)
CN359791 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 4376 to 4934 1 to 559   tiling clone,   559/559
(100 %)
2 diff
(99.7 %id)
BF032167 hypernephroma, Kidney .b 4482 to 5015 1 to 524       524/873
(60 %)
20 diff
(97.8 %id)
BX111752 placenta .b 4639 to 5211 1 to 575       575/575
(100 %)
2 diff
(99.7 %id)
N40124 placenta .b 4639 to 4941 1 to 303       303/303
(100 %)
8 diff
(97.4 %id)
EC535260 Prostate .b 4658 to 4746 1 to 89       89/89
(100 %)
0 diff
(100 %id)
CB162982 Liver .b 4658 to 5131 1 to 475       475/475
(100 %)
3 diff
(99.4 %id)
N42225 placenta .b 4683 to 5144 1 to 474       474/474
(100 %)
31 diff
(93.5 %id)
EC482294 Prostate .b 4707 to 4795 1 to 89       89/89
(100 %)
4 diff
(95.6 %id)
EC453018 Prostate .b 4710 to 4795 1 to 88       88/88
(100 %)
2 diff
(97.8 %id)
EC466892 Prostate .b 4710 to 4795 1 to 84       84/84
(100 %)
2 diff
(97.7 %id)
EC480710 Prostate .b 4710 to 4795 1 to 85       85/85
(100 %)
1 diff
(98.9 %id)
EC539681 Prostate .b 4710 to 4795 1 to 86       86/86
(100 %)
0 diff
(100 %id)
EC554328 Prostate .b 4711 to 4795 1 to 85       85/85
(100 %)
0 diff
(100 %id)
EC496554.
matches multiple genes
Prostate .b 4720 to 4795 12 to 86     also hits gene RRP7B 75/86
(87 %)
6 diff
(93.1 %id)
BM990506 lung, Metastatic Chondrosarcoma .b 4798 to 5447 668 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 650/663
(98 %)
0 diff
(100 %id)
BX407060 brain, fetal brain .b 4799 to 5320 615 to 77       539/646
(83 %)
0 diff
(100 %id)
BX435065 brain, fetal brain .b 4876 to 5434 566 to 1       566/574
(98 %)
15 diff
(97.4 %id)
BY996361   .b 4886 to 5454 610 to 42     Submitted on the opposite strand 569/610
(93 %)
0 diff
(100 %id)
BF057749 pooled germ cell tumors .b 4912 to 5448 538 to 1       538/538
(100 %)
1 diff
(99.9 %id)
BX094483 whole brain .b 4948 to 5443 510 to 15   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 496/496
(100 %)
0 diff
(100 %id)
CF528548 placenta .b 4974 to 5452 494 to 16   tiling clone, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 479/479
(100 %)
0 diff
(100 %id)
AI243627 pooled .b 4988 to 5426 436 to 1       436/436
(100 %)
3 diff
(99.4 %id)
N27002 placenta .b 5015 to 5452 436 to 1       436/437
(99 %)
4 diff
(99.1 %id)
BF062580 colon, colon tumor, RER+ .b 5030 to 5447 419 to 1       419/575
(72 %)
1 diff
(99.9 %id)
AA926830 pooled .b 5039 to 5454 417 to 3       415/425
(97 %)
0 diff
(100 %id)
R56134 whole brain .b 5050 to 5443 419 to 11   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 409/410
(99 %)
25 diff
(94.0 %id)
AI358749 lymph node, lymphoma, follicular mixed small and largecell .b 5058 to 5444 387 to 1       387/387
(100 %)
0 diff
(100 %id)
AI690245 carcinoid, lung .b 5063 to 5445 390 to 8       383/390
(98 %)
0 diff
(100 %id)
AA771985 parathyroid gland, parathyroid tumor .b 5074 to 5448 387 to 15   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 373/373
(100 %)
6 diff
(98.4 %id)
BQ010571 placenta .b 5086 to 5452 382 to 16   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 367/367
(100 %)
0 diff
(100 %id)
AI264065 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 5155 to 5451 299 to 3       297/299
(99 %)
0 diff
(100 %id)
AI364555 anaplastic oligodendroglioma, brain .b 5231 to 5443 227 to 15   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 213/213
(100 %)
1 diff
(99.6 %id)
AA669309 ovary .b 5312 to 5449 138 to 1       138/138
(100 %)
0 diff
(100 %id)
BX326721 Neuroblastoma Cot 50-normalized .c 1 to 500 502 to 4     Submitted on the opposite strand 499/502
(99 %)
0 diff
(100 %id)
BX346502 Neuroblastoma Cot 50-normalized .c 1 to 620 621 to 1     Submitted on the opposite strand 621/621
(100 %)
2 diff
(99.7 %id)
BX367394 Neuroblastoma Cot 50-normalized .c 1 to 741 1 to 737   tiling clone, Submitted on the opposite strand 737/825
(89 %)
12 diff
(98.6 %id)
BX369836 Neuroblastoma Cot 50-normalized .c 1 to 498 498 to 1     Submitted on the opposite strand 498/498
(100 %)
4 diff
(99.2 %id)
BU557403 ovary, teratocarcinoma, cell line .c 47 to 851 1 to 813   tiling clone,   813/886
(91 %)
17 diff
(98.1 %id)
BX387331 Neuroblastoma Cot 50-normalized .c 209 to 1175 958 to 1       958/958
(100 %)
11 diff
(98.9 %id)
BX388241 Neuroblastoma Cot 50-normalized .c 221 to 1175 941 to 1   tiling clone, Submitted on the opposite strand 941/941
(100 %)
20 diff
(97.9 %id)
DB727751 testis .d 1 to 712 1 to 712 E180X P228A R233K tiling clone,   712/713
(99 %)
6 diff
(99.2 %id)
DB027774 testis .e 1 to 570 2 to 571 exact tiling clone, capped   570/570
(100 %)
2 diff
(99.7 %id)
BP270557 small intestine .f 1 to 577 4 to 582   tiling clone,   582/582
(100 %)
5 diff
(99.2 %id)
DA783405 brain .f 6 to 498 2 to 494   capped   493/493
(100 %)
1 diff
(99.8 %id)
BI116383 lung, small cell carcinoma .f 27 to 730 1 to 708 K90Q V130G S131V T132H E133R ... tiling clone,   708/760
(93 %)
13 diff
(98.3 %id)
CN306169 embryonic stem cells, cell lines H1, H7, andH9 .f 93 to 610 1 to 518   tiling clone,   518/518
(100 %)
0 diff
(100 %id)
BQ186325 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .g 1 to 366 1 to 366       366/370
(98 %)
1 diff
(99.8 %id)
TI_151731226   .g 1 to 381 424 to 44   tiling clone,   381/1044
(36 %)
0 diff
(100 %id)
DB092583 testis .g 317 to 851 2 to 537   tiling clone, capped   536/536
(100 %)
3 diff
(99.5 %id)
DA176446 amygdala .h 1 to 495 2 to 499 G46X V47R R48S Q49T G50R ... tiling clone, capped   498/498
(100 %)
4 diff
(99.2 %id)
DB271393 uterus .i-u 1 to 537 2 to 538   tiling clone, capped   537/537
(100 %)
0 diff
(100 %id)
DA334529.
matches multiple genes
hippocampus .i-u 454 to 1024 2 to 572   tiling clone, capped also hits gene kerura 571/571
(100 %)
3 diff
(99.5 %id)
CV377738.
matches multiple genes
colon .i-u 507 to 775 20 to 289     also hits gene kerura 270/289
(93 %)
6 diff
(98.0 %id)
DA785759 brain .j 1 to 495 2 to 496   tiling clone, capped   495/499
(99 %)
2 diff
(99.6 %id)
DA786149 brain .j 3 to 581 2 to 580   capped   579/579
(100 %)
5 diff
(99.2 %id)
BX360468 Placenta Cot 25-normalized .j 18 to 1096 29 to 1097 P37L V38L S58X R59E Q80H ... tiling clone,   1069/1142
(93 %)
37 diff
(96.8 %id)
DA525457 brain .j 28 to 580 2 to 555   capped   554/554
(100 %)
2 diff
(99.7 %id)
DA486385 brain .j 33 to 559 2 to 528   capped   527/527
(100 %)
3 diff
(99.5 %id)
DA683021   .j 33 to 523 2 to 492   capped   491/491
(100 %)
1 diff
(99.8 %id)
CN306166 embryonic stem cells, cell lines H1, H7, andH9 .j 41 to 729 1 to 689       689/689
(100 %)
6 diff
(99.2 %id)
DA523063 brain .j 209 to 765 2 to 558   tiling clone, capped   557/557
(100 %)
0 diff
(100 %id)
TI_154196380   .k 1 to 626 9 to 636   tiling clone,   628/998
(62 %)
29 diff
(97.1 %id)
TI_154198012   .k 9 to 756 103 to 844 L53M G61X P72R D73T L74W ... tiling clone,   742/904
(82 %)
31 diff
(96.6 %id)
BF771214 epid_tumor .l-u 1 to 278 1 to 278   tiling clone,   278/278
(100 %)
0 diff
(100 %id)
BF772545.
matches multiple genes
epid_tumor .l-u 1 to 426 1 to 425 V2A F14L P22Y S32Y P34D ... tiling clone, also hits gene foyfer 425/425
(100 %)
15 diff
(96.5 %id)
F32212 pectoral muscle (after mastectomy) Gene RRP7A, variant not shown         Suspected internal deletion, this clone was ignored    
W44890 parathyroid gland, parathyroid tumor Gene RRP7A, variant not shown         Suspected internal deletion, this clone was ignored    
AI220047 pooled Gene RRP7A, variant not shown         Submitted on the opposite strand    
AI763109 B-cell, chronic lymphotic leukemia Gene RRP7A, variant not shown         Submitted on the opposite strand    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i-u, .j, .k, .l-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes C